Tenure Track Faculty Positions
Georgetown Lombardi Comprehensive Cancer Center
The Georgetown Lombardi Comprehensive Cancer Center (LCCC) and Georgetown University School of Medicine are pleased to announce multiple opportunities for outstanding investigators in diverse areas of cancer research as part of a significant expansion of the cancer center research portfolio. These tenure track positions will be assigned to cancer center programs in breast cancer, cancer prevention and control and molecular oncology/experimental therapeutics. Applicants from diverse scientific and clinical disciplines are welcome. Appointments will be accompanied by significant financial resources to support faculty research.
The Georgetown University Medical Center is an academic health sciences center in Washington, DC, and serves a broad range of medical and biomedical graduate education and training activities, clinical and translational sciences, and patient care with MedStar Health. In addition to the medical school, there is a school of nursing and health studies, and schools of law, public policy, business, arts and sciences, and international affairs.
The LCCC is an NCI-designated Consortium Comprehensive Cancer Center, with >125 members conducting cutting-edge research and clinical trials across the region, nationally, and internationally. With campuses in Washington, DC and Bergen County, NJ, the cancer center spans a diverse catchment area and leads groundbreaking discoveries in molecular oncology, experimental therapeutics, breast cancer research, hematologic malignancies, and cancer population sciences. Combined, LCCC and its research partners have access to the largest clinical network in the mid-Atlantic region, and boast a comprehensive collection of research shared resources.
Successful candidates will have a doctoral and/or medical degree and a focus on areas of cancer research that are relevant to the LCCC mission. Applicants are required to have a strong track record of cancer-relevant publications and current peer reviewed, cancer-focused funding. The Breast Cancer Research Program has three broad aims: 1) responsiveness to systemic therapies, 2) interaction mechanisms connecting the tumor macro and micro environment to breast cancer prevention and progression, and 3) novel strategies for breast cancer therapy. The Cancer Prevention and Control Program has the following aims: 1) risk factors and biomarkers for cancer and early detection, 2) primary and secondary cancer prevention strategies, and 3) policy-relevant research on cancer treatments and survivorship. The Molecular Oncology and Experimental Therapeutic Research Program has three overarching and interrelated foci: 1) identifying pathways and molecular targets in cancer, 2) understanding and exploiting the crosstalk between cancer cells, the tumor microenvironment and the immune system, and, 3) evaluating cancer genomics and epigenetics. LCCC encourages cross-cutting research that includes clinical translation and interactions with a full spectrum of LCCC disease-based clinical research groups. Particular areas of emphasis within these disciplines include data science/cancer genomics, cancer survivorship, immunotherapy and minority health/health disparities, with an emphasis on needs in the LCCC catchment area. Expertise in cancer-relevant computational biology and research pathology will be particularly welcome, as will a research focus on hematology malignancies. All applicants will be carefully screened and considered at the Assistant, Associate, or Full Professor levels.
To apply, please send a cover letter and CV as a single PDF to Ms. Sharon Levy (SGL5@georgetown.edu) with “Lombardi Faculty Search” in the subject line. Individual inquiries may be directed to:
Louis M. Weiner, MD
Director, Georgetown Lombardi Comprehensive Cancer Center
Chair, Department of Oncology, Georgetown University Medical Center